Literature DB >> 15657200

Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles.

I Anguera1, A Del Río, J M Miró, X Matínez-Lacasa, F Marco, J R Gumá, G Quaglio, X Claramonte, A Moreno, C A Mestres, E Mauri, M Azqueta, N Benito, C García-de la María, M Almela, M-J Jiménez-Expósito, O Sued, E De Lazzari, J M Gatell.   

Abstract

OBJECTIVE: To evaluate the incidence and the clinical and echocardiographic features of infective endocarditis (IE) caused by Staphylococcus lugdunensis and to identify the prognostic factors of surgery and mortality in this disease.
DESIGN: Prospective cohort study.
SETTING: Study at two centres (a tertiary care centre and a community hospital). PATIENTS: 10 patients with IE caused by S lugdunensis in 912 consecutive patients with IE between 1990 and 2003.
METHODS: Prospective study of consecutive patients carried out by the multidisciplinary team for diagnosis and treatment of IE from the study institutions. English, French, and Spanish literature was searched by computer under the terms "endocarditis" and "Staphylococcus lugdunensis" published between 1989 and December 2003. MAIN OUTCOME MEASURES: Patient characteristics, echocardiographic findings, required surgery, and prognostic factors of mortality in left sided cases of IE.
RESULTS: 10 cases of IE caused by S lugdunensis were identified at our institutions, representing 0.8% (four of 467), 1.5% (two of 135), and 7.8% (four of 51) of cases of native valve, prosthetic valve, and pacemaker lead endocarditis in the non-drug misusers. Native valve IE was present in four patients (two aortic, one mitral, and one pulmonary), prosthetic valve aortic IE in two patients, and pacemaker lead IE in the other four patients. All patients with left sided IE had serious complications (heart failure, periannular abscess formation, or shock) requiring surgery in 60% (three of five patients) of cases with an overall mortality rate of 80% (four of five patients). All patients with pacemaker IE underwent combined medical treatment and surgery, and mortality was 25% (one patient). In total 59 cases of IE caused by S lugdunensis were identified in a review of the literature. The combined analysis of these 69 cases showed that native valve IE (53 patients, 77%) is characterised by mitral valve involvement and frequent complications such as heart failure, abscess formation, and embolism. Surgery was needed in 51% of cases and mortality was 42%. Prosthetic valve endocarditis (nine of 60, 13%) predominated in the aortic position and was associated with abscess formation, required surgery, and high mortality (78%). Pacemaker lead IE (seven of 69, 10%) is associated with a better prognosis when antibiotic treatment is combined with surgery.
CONCLUSIONS: S lugdunensis IE is an uncommon cause of IE, involving mainly native left sided valves, and it is characterised by an aggressive clinical course. Mortality in left sided native valve IE is high but the prognosis has improved in recent years. Surgery has improved survival in left sided IE and, therefore, early surgery should always be considered. Prosthetic valve S lugdunensis IE carries an ominous prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657200      PMCID: PMC1768720          DOI: 10.1136/hrt.2004.040659

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  50 in total

Review 1.  Destructive native valve endocarditis caused by Staphylococcus lugdunensis.

Authors:  S J Burgert; M T LaRocco; S Wilansky
Journal:  South Med J       Date:  1999-08       Impact factor: 0.954

2.  Staphylococcus lugdunensis endocarditis after angiography.

Authors:  H Polenakovik; T Herchline; C Bacheller; J Bernstein
Journal:  Mayo Clin Proc       Date:  2000-06       Impact factor: 7.616

Review 3.  Pacemaker-related endocarditis. Report of 7 cases and review of the literature.

Authors:  M Laguno; O Miró; C Font; A de la Sierra
Journal:  Cardiology       Date:  1998       Impact factor: 1.869

4.  Pacemaker endocarditis due to Staphylococcus lugdunensis: report of two cases.

Authors:  S Bobin; A Durand-Dubief; D Bouhour; G Kirkorian; F Vandenesch; J Etienne; M Ballet-Mechain; D Peyramond
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

5.  Mitral and aortic valve endocarditis due to Staphylococcus lugdunensis.

Authors:  A Renzulli; A Della Corte; M Torella; G Dialetto; M Cotrufo
Journal:  Tex Heart Inst J       Date:  2000

Review 6.  Staphylococcus lugdunensis endocarditis: a complication of vasectomy?

Authors:  F C Fervenza; G E Contreras; K N Garratt; J M Steckelberg
Journal:  Mayo Clin Proc       Date:  1999-12       Impact factor: 7.616

Review 7.  Staphylococcus lugdunensis pulmonary valve endocarditis in a patient on chronic hemodialysis.

Authors:  S Kamaraju; K Nelson; D N Williams; W Ayenew; K S Modi
Journal:  Am J Nephrol       Date:  1999       Impact factor: 3.754

8.  Staphylococcus lugdunensis endocarditis in a young, previously healthy female.

Authors:  E Wasserman; L Lombard; G Walzl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-04       Impact factor: 3.267

9.  Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience.

Authors:  R Patel; K E Piper; M S Rouse; J R Uhl; F R Cockerill; J M Steckelberg
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

Review 10.  [7 cases of Staphylococcus lugdunensis infection].

Authors:  V Sanchís-Bayarri Vaillant; R Llucian Rambla; V Sanchís-Bayarri Bernal
Journal:  An Med Interna       Date:  1999-07
View more
  54 in total

Review 1.  Recurrent Staphylococcus warnerii prosthetic valve endocarditis: a case report and review.

Authors:  Ferhat Arslan; Nese Saltoglu; Birgül Mete; Ali Mert
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-04-23       Impact factor: 3.944

2.  IsdC from Staphylococcus lugdunensis induces biofilm formation under low-iron growth conditions.

Authors:  Antonino Missineo; Antonella Di Poto; Joan A Geoghegan; Simonetta Rindi; Simon Heilbronner; Valentina Gianotti; Carla Renata Arciola; Timothy J Foster; Pietro Speziale; Giampiero Pietrocola
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  Septic Embolic Stroke Resulting From Staphylococcus lugdunensis Endocarditis.

Authors:  Htoo Kyaw; Atif Z Shaikh; Gokul Yaratha; Misra Deepika
Journal:  Ochsner J       Date:  2017

4.  Fatal myocardial necrosis caused by Staphylococcus lugdunensis and cytomegalovirus in a patient with scleroderma.

Authors:  Laura Pirilä; Karl-Ove Söderström; Marja Hietarinta; Jari Jalava; Ville Kytö; Auli Toivanen
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

5.  fbl gene as a species-specific target for Staphylococcus lugdunensis identification.

Authors:  Kalliopi-Stavroula Chatzigeorgiou; Nikolaos Siafakas; Efthymia Petinaki; Loukia Zerva
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Conservative management of a brain abscess in a patient with Staphylococcus lugdunensis endocarditis.

Authors:  S Gianella; S Ulrich; B Huttner; R Speich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

7.  Fatal prosthetic valve endocarditis of the CoreValve ReValving System.

Authors:  Michael Gotzmann; Andreas Mügge
Journal:  Clin Res Cardiol       Date:  2011-04-03       Impact factor: 5.460

8.  Truncated Autoinducing Peptides as Antagonists of Staphylococcus lugdunensis Quorum Sensing.

Authors:  Christopher P Gordon; Shondra D Olson; Jessica L Lister; Jeffrey S Kavanaugh; Alexander R Horswill
Journal:  J Med Chem       Date:  2016-09-15       Impact factor: 7.446

9.  The characteristics and outcome of infective endocarditis involving implantable cardiac devices.

Authors:  Eugene Athan
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 10.  From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.

Authors:  Kristi L Frank; José Luis Del Pozo; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.